MedTrace Logo

Effect of Kinesiotaping Versus Endurance Exercise on Postmenopausal Low Back Pain

NCT06771310 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-01-13

No results posted yet for this study

Summary

This study will be conducted to determine the effect of kinesiotaping versus endurance exercise on postmenopausal low back pain.

Conditions

  • Low Back Pain

Interventions

OTHER

Endurance exercise

The exercise-training program will be consisted of 10 minutes warming up, 30 minutes of treadmill walking, and 10 min cooling down three times per week. Warming up: It will be in the form of stretching of muscle groups for 10 minutes (3-5 stretch for the key muscle group (iliopsoas muscle, gluteus maximus ,quadriceps ,tibialis anterior , calf muscle, hold for 20-30 seconds), before the actual aerobic training session. Actual session: Participants will receive aerobic exercises in the form of Moderate aerobic exercise training in the form of 30 min of treadmill walking and corresponding to a target heart rate of 65% to 75% of HR max (Maximum HR = 220 - Age ) to be gradually achieved and maintained throughout the training program. Cooling down: It will be in the form of a treadmill walking at very slow speed for ten minutes.

OTHER

Kinesiotaping

The participants will be asked to assume standing position then to flex back to reach its maximum point. * Two bands, 1 on each side of the lumbar spine, will be applied vertically from the lower posterior iliac crest region to the upper twelfth rib region, with inhibition technique. * The remaining 2 bands will be attached horizontally, with space correction technique. * All 4 bands will be placed to allow for 50% longitudinal stretching. The stretching directions for the vertical and horizontal applications were bottom-up and sideways, respectively.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Hossam Hussien, Professor · Al-Azhar University

  • Soheir El-kosery, Professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-16
Primary Completion
2025-05-01
Completion
2025-05-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06771310 on ClinicalTrials.gov